This site is intended for healthcare professionals
News

Phase III trial of Padcev meets primary endpoint in urothelial cancer.- Astellas Pharma and Seattle Genetics

Read time: 1 mins
Last updated:20th Sep 2020
Published:19th Sep 2020
Condition: Bladder Cancer
Type: drug
Register free for full access to medthority.com